LIFECORE BIOMEDICAL, INC. current report, Q1 FY2015

Business Context and Reporting Period

This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) for the reporting period ending March 31, 2015. The filing announces the consolidated financial results for the third quarter of fiscal year 2015.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.

Material Changes

The filing text does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that the third-quarter results have been issued.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information in the press release (Exhibit 99.1) is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.

Investor Verification Checklist

  • Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
  • Review Exhibit 99.1 (Press Release dated March 31, 2015) for actual financial figures and operational details.
  • Confirm the specific fiscal year definition used by Landec Corporation to ensure accurate period comparison.